Novartis and Genentech had accused Korean rival of “imminent infringement” through marketing of biosimilar | 1yr
Pharmaceutical/Medical - Page 4
Charles Atkinson to replace Todd Kingma, who retires from Perrigo for a second time | 1yr
Veteran IP litigator Hiroshi Sheraton and M&A lawyer Luciana Griebel join in London | 1yr
The way the request was processed still raises ‘significant concerns’, says the firm | 1yr
This guide provides a comparative overview of class actions and collective redress mechanisms across key jurisdictions. | 2mos
Alexander Klett, Christoph Mikyska and Sebastian Dexheimer move over from Reed Smith and Milbank | 1yr
Pan-European patent court delivers first revocation judgment a year and a month after opening | 1yr
Any regulatory changes to drug patents and pricing should be wary of stifling innovation, writes Neal Gerber Eisenberg lawyer Thomas Campbell | 1yr
Trio of partners join from Wilson Sonsini and boutique Hooper Lundy & Bookman as Orrick continues life sciences push | 1yr
Glucose monitoring patent revoked across 17 UPC member states in ongoing dispute with rival Abbott | 2yrs
Mathys & Squire patent litigator Stephen Garner discusses changes to EU pharmaceutical legislation and the impact on IP rights | 2yrs
Freshfields, Taylor Wessing and Powell Gilbert advise on closely watched London High Court dispute | 2yrs
Swedish companies are imposing age restrictions on their beauty products. Bird & Bird lawyers Caroline Grotenfelt, Julia Jansson and Beatrice Rälg ask if more countries will follow suit? | 2yrs
Team moves over from Lerner David strengthening medical device practice | 2yrs
Decision upholds earlier ruling revoking patent covering the drug Xarelto, further clearing way for generic manufacturers to enter the lucrative market | 2yrs
Led by respected life sciences litigator Siegmund Gutman, the team of 10 move over from Proskauer Rose | 2yrs
Düsseldorf local division orders US life sciences company Curio Bioscience to stop selling its products in Germany, France and Sweden in dispute with rival 10x Genomics | 2yrs
UK pharmaceutical firm enters the fray in the battle over mRNA technology used to develop blockbuster vaccines | 2yrs
Irena Royzman is fourth IP partner to join tech-focused firm this year | 2yrs
Bakers’ South Africa M&A co-head Angela Simpson moves over alongside three more lawyers | 2yrs
Tech-focused firm sees PEP grow 8.2% following almost 20% decline in 2022 | 2yrs